Prabhakar Chebiyyam

This inventor holds 5 USPTO granted patents. Top assignees: Dr. Reddy's Laboratories, Incorporated, Dr. Reddy's Research Foundation. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prabhakar Chebiyyam. Retrieved from https://idiyas.com/inventor/prabhakar-chebiyyam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 5.3

ph-index = 1

Company Filing History:

5 out of 187

Dr. Reddy's Laboratories, Incorporated

patents

1 out of 23

Dr. Reddy's Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2002-2007

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7241895 - Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation (2007-07-10),

2. 7223881 - Process for the preparation of new antidiabetic agents (2007-05-29),

3. 6897199 - Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds (2005-05-24),

4. 6531596 - Process for the preparation of new antidiabetic agents (2003-03-11),

5. 6469167 - Process for the preparation of thiazolidine-2,4-dione derivatives (2002-10-22),

Title: Prabhakar Chebiyyam: Innovator in Antidiabetic Compounds

Introduction

Prabhakar Chebiyyam is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic agents. With a total of 5 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

One of his latest patents is focused on the polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate. This invention relates to novel polymorphic and pseudopolymorphic forms that exhibit enhanced activity as antidiabetic agents compared to previously known compounds. Another significant patent involves an improved process for the preparation of novel antidiabetic compounds, where specific chemical structures are optimized for better efficacy.

Career Highlights

Throughout his career, Prabhakar has worked with prominent organizations such as Dr. Reddy's Laboratories and Dr. Reddy's Research Foundation. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Prabhakar has collaborated with notable colleagues, including Ramabhadra Sarma Mamillapalli and Om Reddy Gaddam. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.

Conclusion

Prabhakar Chebiyyam's contributions to the field of antidiabetic agents highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science and enhancing the quality of life for patients.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]